Jaguar Health (JAGX) Interest Expenses (2014 - 2026)
Jaguar Health (JAGX) reported Interest Expenses of $699000.0 for Q1 2026, up 1348.21% year-over-year from $48266.3 in Q1 2025, and up 429.55% quarter-over-quarter from $132000.0 in Q4 2025.
Jaguar Health (JAGX) Interest Expenses (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Interest Expenses data on file, last reported at $699000.0 in Q1 2026.
- Interest Expenses for Q1 2026 came in at $699000.0, up 1348.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $822000.0 (up 288.53% YoY), and the FY2025 annual result was $67000.0, down 71.0% from the prior year.
- Interest Expenses rose to $699000.0 in Q1 2026 per JAGX's latest filing, from $132000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $4.2 million in Q1 2022 and troughed at -$162000.0 in Q3 2024.
- A 5-year average of $1.1 million and a median of $374000.0 in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses jumped 209600.0% in 2022, then sank 144.35% in 2024.
- A 5-year view of Interest Expenses shows it stood at $2.6 million in 2022, then slumped by 90.58% to $248000.0 in 2023, then tumbled by 144.35% to -$110000.0 in 2024, then soared by 220.0% to $132000.0 in 2025, then surged by 429.55% to $699000.0 in 2026.
- Business Quant data shows JAGX's Interest Expenses at $699000.0 in Q1 2026, $132000.0 in Q4 2025, and $6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -5.58 Mn |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 699,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 699,000.00 |
| Mar 31, 2026 | 699,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | -15,000.00 |
| Jun 30, 2025 | -15,000.00 |
| Mar 31, 2025 | -56,000.00 |
| Mar 31, 2025 | -56,000.00 |
| Dec 31, 2024 | -110,000.00 |
| Dec 31, 2024 | -110,000.00 |
| Sep 30, 2024 | -162,000.00 |
| Sep 30, 2024 | -162,000.00 |
| Jun 30, 2024 | -108,000.00 |
| Jun 30, 2024 | -108,000.00 |
| Mar 31, 2024 | 611,000.00 |
| Mar 31, 2024 | 611,000.00 |
| Dec 31, 2023 | 248,000.00 |
| Dec 31, 2023 | 248,000.00 |